Back to search

Transferred Herpes Simplex Virus Immunity after Stem‐Cell Transplantation: Clinical Implications

Data up to Jan 2025

Published2003
Citations44
References33

Total Citations Per Year

Abstract

References (33)

A double‐blind, placebo‐controlled trial

1986 • 1,281 citations

Infusion of cytomegalovirus (CMV)–specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

2002 • 710 citations

Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study

1996 • 677 citations

Acyclovir Prophylaxis of Herpes-Simplex-Virus Infections

1981 • 593 citations

Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera

1988 • 542 citations

A Prospective Study of New Infections with Herpes Simplex Virus Type 1 and Type 2

1999 • 500 citations

Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide

1994 • 373 citations

Herpes Simplex Virus Pneumonia

1982 • 329 citations

Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation

1984 • 261 citations

Infection with Herpes Simplex Virus and Cell-Mediated Immunity after Marrow Transplant

1980 • 232 citations

Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes

2001 • 213 citations

Esophageal Infections in Immunosuppressed Patients After Marrow Transplantation

1985 • 187 citations

Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease

1998 • 185 citations

Famciclovir for the Suppression of Symptomatic and Asymptomatic Herpes Simplex Virus Reactivation in HIV-Infected Persons: A Double-Blind, Placebo-Controlled Trial

1998 • 180 citations

Resistant Herpes Simplex Virus Type 1 Infection: An Emerging Concern after Allogeneic Stem Cell Transplantation

2000 • 166 citations

Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial.

1983 • 150 citations

Infections Caused by Herpes Simplex Virus in the Immunocompromised Host: Natural History And Topical Acyclovir Therapy

1984 • 132 citations

Cyclosporine or Cyclosporine Plus Methylprednisolone for Prophylaxis of Graft-Versus-Host Disease: A Prospective, Randomized Trial

1997 • 129 citations

Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a high-prevalence population

1987 • 124 citations

Resistance to Antiviral Drugs in Herpes Simplex Virus Infections among Allogeneic Stem Cell Transplant Recipients: Risk Factors and Prognostic Significance

2000 • 123 citations

European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

1996 • 106 citations

Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation

2002 • 81 citations

Acyclovir prophylaxis in bone marrow transplant recipients.

1985 • 67 citations

Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus

1987 • 66 citations

Recurrent Infection with Herpes Simplex Virus after Marrow Transplantation: Role of the Specific Immune Response and Acyclovir Treatment

1984 • 63 citations

Clearance of Persistent Hepatitis B Virus Infection in Chinese Bone Marrow Transplant Recipients Whose Donors Were Anti–Hepatitis B Core– and Anti–Hepatitis B Surface Antibody–Positive

1998 • 55 citations

Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia [letter]

1994 • 46 citations

Comparison of diploid fibroblast and rabbit kidney tissue cultures and a diploid fibroblast microtiter plate system for the isolation of herpes simplex virus

1988 • 37 citations

Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies.

1995 • 27 citations

Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia.

1991 • 26 citations

Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide

1994 • 21 citations

Cyclosporine or Cyclosporine Plus Methylprednisolone for Prophylaxis of Graft-Versus-Host Disease: A Prospective, Randomized Trial

1997 • 9 citations

Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia [letter]

1994 • 3 citations

Cited By (0)

Loading...
Transferred Herpes Simplex Virus Immunity after Stem‐Cell Transplantation: Clinical… (2003) – The Journal of Infectious Diseases | Metascience Observatory Explorer